Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 560 studies with search of: | "Irinotecan" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
High Dose CPT-11 in Recurrent Unresectable Malignant Glioma
|
||||
2 | Recruiting |
Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC
|
||||
3 | Recruiting |
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
|
||||
4 | Recruiting |
Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer
|
||||
5 | Active, not recruiting |
Dose-Finding Study of E7070 in Combination With Irinotecan
|
||||
6 | Completed |
Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas
|
||||
7 | Active, not recruiting |
Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
|
||||
8 | Active, not recruiting |
Ph I SU011248 + Irinotecan in Treatment of Pts w MG
|
||||
9 | Recruiting |
Avastin in Combo w XRT & Temozolomide , Followed by Avastin, Temozolomide & Irinotecan for GBM & Gliosarcomas
|
||||
10 | Active, not recruiting |
Irinotecan (Camptosar) in Patients With Advanced Sarcomas
|
||||
11 | Recruiting |
Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin
|
||||
12 | Recruiting |
Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC
|
||||
13 | Recruiting |
Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer
|
||||
14 | Active, not recruiting |
Cetuximab Combined With Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL)
|
||||
15 | Completed |
Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
|
||||
16 | Recruiting |
Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer
|
||||
17 | Recruiting |
Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme
|
||||
18 | Active, not recruiting |
Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
|
||||
19 | Active, not recruiting |
A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer
|
||||
20 | Not yet recruiting |
Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |